Glenmark takes mometasone OTC in Russia

25 April 2019 - Deborah Wilkes


Glenmark Pharmaceuticals is set to launch Momat Rino (mometasone furoate) as an OTC medicine in Russia.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: